SMAD4 and neoplasm: Future work should include experimental interrogation of SMAD4, BMPR1A, and other TGF-β pathway alterations in preclinical models, as well as advanced approaches such as single-cell sequencing and spatial biology to dissect tumor–microenvironment interactions.